“…1 In type 2 mosaicism, a heterozygous embryo harbours a germline mutation for an autosomal dominant skin disease, and a segmental area of the skin that is far more severely affected as a result of loss of heterozygosity for the underlying mutation, giving rise to either homozygosity or hemizygosity. 3,4 Here we report a patient with congenital, pronounced, unilateral lesions of Gorlin syndrome (naevoid basal cell carcinoma syndrome, OMIM 109400), and we present, for the first time, molecular data providing evidence of a type 2 segmental manifestation of this autosomal dominant disorder. 2 To date, however, molecular proof of the concept has been provided in only a few skin disorders.…”